Eli Lilly’s AI collaborations via TuneLab cut preclinical timelines by up to 30% and reduce attrition rates, democratizing drug discovery for smaller firms with enhanced data privacy. Eli Lilly&...
Advances in AI and genomics enable tailored dietary plans, improving weight management and chronic disease prevention, as shown by recent studies and market growth projections. AI and genomics are tra...
Analysis of ChatGPT and Gemini’s dietary advice for IBS patients shows mixed accuracy, with trends highlighting AI’s role and the need for professional oversight. Recent studies assess AI ...
AI chatbots like ChatGPT and Gemini offer discreet gynecological advice in Lebanon, reducing stigma and improving access, with ethical concerns addressed through cultural sensitivity. AI chatbots prov...
Advances in AI and genomics enable tailored diet plans that improve weight management and prevent chronic diseases, with recent studies showing up to 25% risk reduction. AI and genetic data are transf...
Recent AI advancements in liquid biopsies improve chronic disease detection, with studies showing high sensitivity and reduced false positives for conditions such as MASH, enhancing preventive healthc...
This article analyzes the critical role of AI product owners in healthcare, focusing on FDA regulations, real-world case studies, and the balance between innovation and patient safety for improved out...
This article analyzes how AI product owners in healthcare balance innovation with accountability, using real-world examples like FDA clearances and Epic integrations to ensure patient safety and ethic...
The AI scribe market is booming, with startups like Heidi Health and Abridge reducing physician burnout and improving efficiency, while facing competition from Epic and challenges from AI giants and r...
Artificial intelligence is accelerating drug discovery for rare diseases, reducing costs by up to 50% and shortening timelines, enabling bespoke therapies and improving healthcare equity globally. AI ...
